ANI logo.png
ANI Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023
September 18, 2023 16:05 ET | ANI Pharmaceuticals, Inc.
BAUDETTE, Minn., Sept. 18, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey,...
ANI logo.png
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Tablets USP
September 12, 2023 06:50 ET | ANI Pharmaceuticals, Inc.
BAUDETTE, Minn., Sept. 12, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval...
ANI logo.png
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.1%
August 28, 2023 06:50 ET | ANI Pharmaceuticals, Inc.
BAUDETTE, Minn., Aug. 28, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for...
ANI logo.png
ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
August 24, 2023 06:50 ET | ANI Pharmaceuticals, Inc.
BAUDETTE, Minn., Aug. 24, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey,...
ANI logo.png
ANI Pharmaceuticals Appoints Healthcare Executive Matthew J. Leonard to its Board of Directors
August 23, 2023 06:50 ET | ANI Pharmaceuticals, Inc.
-- Mr. Leonard is an accomplished leader with 35 years of pharmaceuticals and healthcare experience -- Mr. Leonard has significant expertise in pharmacy benefits management, health insurance, and...
ANI logo.png
ANI Pharmaceuticals Reports Record Second Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance  
August 09, 2023 06:50 ET | ANI Pharmaceuticals, Inc.
Second Quarter 2023 Financial Results -- Record quarterly net revenues of $116.5 million, representing year-over-year growth of 57.8%; net income available to common shareholders of $5.8 million and...
ANI logo.png
ANI Pharmaceuticals to Discuss Second Quarter 2023 Financial Results on August 9, 2023, at 8:30 a.m. ET
July 31, 2023 07:17 ET | ANI Pharmaceuticals, Inc.
BAUDETTE, Minn., July 31, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2023 financial...